Advertisement
Screener

Savara Inc (SVRA) Other

Savara Inc Other

Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.

  • 2020-05-07: Form 10-Q; Item Stock registered under Section 12(b); As filed Common Stock, par value $0.001 per share · SVRA · NASDAQ.
  • 2020-03-12: Form 10-K; Item Stock registered under Section 12(b); As filed Common Stock, par value $0.001 per share · SVRA · NASDAQ.
  • 2019-11-07: Form 10-Q; Item Stock registered under Section 12(b); As filed Common Stock, par value $0.001 per share · SVRA · NASDAQ.
  • 2018-11-07: Form 10-Q; Item Smaller reporting company; As filed No.
FiledFormItemAs filed
2020-05-0710-QStock registered under Section 12(b)Common Stock, par value $0.001 per share · SVRA · NASDAQ
2020-03-1210-KStock registered under Section 12(b)Common Stock, par value $0.001 per share · SVRA · NASDAQ
2019-11-0710-QStock registered under Section 12(b)Common Stock, par value $0.001 per share · SVRA · NASDAQ
2018-11-0710-QSmaller reporting companyNo

Similar stocks

Stock NameCountryMarket CapPE Ratio
MoonLake Immunotherapeutics (MLTX)Switzerland$1.031B-5.43
MANNKIND CORP (MNKD)United States$1.058B-30.41
Alto Neuroscience, Inc. (ANRO)United States$1.065B-11.02
Pacira BioSciences, Inc. (PCRX)United States$1.020B69.03
Janux Therapeutics, Inc. (JANX)United States$1.019B-9.15
Corvus Pharmaceuticals, Inc. (CRVS)United States$0.994B-23.25
Amphastar Pharmaceuticals, Inc. (AMPH)United States$1.116B10.93
Kura Oncology, Inc. (KURA)United States$0.967B-3.29
Arbutus Biopharma Corp (ABUS)$0.965B6.19
Seaport Therapeutics, Inc. (SPTX)United States$1.131B